Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Edward A. Stadtmauer, MD

Edward A. Stadtmauer, MD Physician

Section Chief, Hematologic Malignancies
Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Stadtmauer is a Penn Medicine employed physician.

About Dr. Edward A. Stadtmauer

Recognized in Philadelphia Magazine's annual Top Docs issue from 2005 - 2008, 2011, and 2013 - 2016

Recognized by America's Top Doctors, 2007, 2008, 2010, 2011-14

Recognized by Best Doctors in America 2003-2004, 2005-2006, 2007-2008, 2009-2010, 2011-2012, 2013-2014

Clinical Specialties

Specialty:

  • Medicine
    • Hematology
    • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 1988
  • Internal Medicine, 1986
  • Medical Oncology, 1989

Clinical Expertise:

  • Autologous Stem Cell Transplantation
  • Blood Cancer
  • Bone Marrow Transplant
  • Multiple Myeloma
  • Stem Cell Transplant

Description of Clinical Expertise

Myeloma, Leukemia, Lymphoma and Bone Marrow and Stem Cell Transplant

Practice Locations and Appointments

  • Abramson Cancer Center

    Perelman Center for Advanced Medicine West Pavilion, 2nd Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-PENN (7366)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: University of Pennsylvania School of Medicine
Residency: Bronx Municipal Hospital - Albert Einstein College
Fellowship: Hospital of the University of Pennsylvania

Memberships

American College of Physicians, Fellow, National American Federation for Clinical Research, National American Society for Blood and Marrow Transplantation, National American Society of Clinical Oncology, National American Society of Hematology, National Autologous Bone Marrow Transplant Registry (ABMTR/CIBMTR), National Bone Marrow Transplant Clinical Trials Network, National Eastern Cooperative Oncology Group, National Foundation for the Accreditation of Hematopoietic Cell Therapy, National International Myeloma Working Group, International Membership in National Scientific Review Panels, National NIAID Hematopoietic Stem Cell Transplantation Data Safety Monitoring Board (HSCT DSMB), National

Hospital Affiliation

Dr. Stadtmauer is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Description of Research Expertise:

Clinical trials, Bone Marrow Transplant

Selected Publications:

Garfall, Alfred L; Stadtmauer, Edward A; June, Carl H.: Chimeric Antigen Receptor T Cells in Myeloma. New England Journal of Medicine 374 (2): 194,2016.

Shah JJ, Stadtmauer EA, Abonour R, Cohen AD, Bensinger WI, Gasparetto C, Kaufman JL, Lentzsch S, Vogl DT, Gomes CL, Pascucci N, Smith DD, Orlowski RZ, Durie BG.: Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma. Blood 126 (20): 2284-90,2015.

Garfall, Alfred L; Maus, Marcela V; Hwang, Wei-Ting; Lacey, Simon F; Mahnke, Yolanda D; Melenhorst, J Joseph; Zheng, Zhaohui; Vogl, Dan T; Cohen, Adam D; Weiss, Brendan M; Dengel, Karen; Kerr, Naseem D S; Bagg, Adam; Levine, Bruce L; June, Carl H; Stadtmauer, Edward A.: Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma. New England Journal of Medicine 373 (11): 1040-7,2015.

Rapoport, Aaron P; Stadtmauer, Edward A; Binder-Scholl, Gwendolyn K; Goloubeva, Olga; Vogl, Dan T; Lacey, Simon F; Badros, Ashraf Z; Garfall, Alfred; Weiss, Brendan; Finklestein, Jeffrey; Kulikovskaya, Irina; Sinha, Sanjoy K; Kronsberg, Shari; Gupta, Minnal; Bond, Sarah; Melchiori, Luca; Brewer, Joanna E; Bennett, Alan D; Gerry, Andrew B; Pumphrey, Nicholas J; Williams, Daniel; Tayton-Martin, Helen K; Ribeiro, Lilliam; Holdich, Tom; Yanovich, Saul; Hardy, Nancy; Yared, Jean; Kerr,: NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma. Nature Medicine 21 (8): 914-21,2015.

Reshef, Ran; Huffman, Austin P; Gao, Amy; Luskin, Marlise R; Frey, Noelle V; Gill, Saar I; Hexner, Elizabeth O; Kambayashi, Taku; Loren, Alison W; Luger, Selina M; Mangan, James K; Nasta, Sunita D; Richman, Lee P; Sell, Mary; Stadtmauer, Edward A; Vonderheide, Robert H; Mick, Rosemarie; Porter, David L.: High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning. Journal of Clinical Oncology 33 (21): 2392-8,2015.

Bagley, Stephen J; Sehgal, Alison R; Gill, Saar; Frey, Noelle V; Hexner, Elizabeth O; Loren, Alison W; Mangan, James K; Porter, David L; Stadtmauer, Edward A; Reshef, Ran; Luger, Selina M.: Acute cholecystitis is a common complication after allogeneic stem cell transplantation and is associated with the use of total parenteral nutrition. Biology of Blood & Marrow Transplantation 21 (4): 768-71,2015.

Waxman, A J; Mick, R; Garfall, A L; Cohen, A; Vogl, D T; Stadtmauer, E A; Weiss, B M.: Classifying ultra-high risk smoldering myeloma. Leukemia 29 (3): 751-3,2015.

Frosch, Zachary; Luskin, Marlise R; Landsburg, Daniel J; Schuster, Stephen J; Svoboda, Jakub; Loren, Alison W; Porter, David L; Stadtmauer, Edward A; Nasta, Sunita D.: R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphoma. Clinical lymphoma, myeloma & leukemia 15 (2): 92-7,2015.

Appelbaum, Frederick R; Anasetti, Claudio; Antin, Joseph H; Atkins, Harold; Davies, Stella; Devine, Steven; Giralt, Sergio; Heslop, Helen; Laport, Ginna; Lee, Stephanie J; Logan, Brent; Pasquini, Marcelo; Pulsipher, Michael; Stadtmauer, Edward; Wingard, John R; Horowitz, Mary M.: Blood and marrow transplant clinical trials network state of the Science Symposium 2014. Biology of Blood & Marrow Transplantation 21 (2): 202-24,2015.

Freytes, Cesar O; Toro, Juan J; Yeh, Rosa F; Stadtmauer, Edward A; Ratanatharathorn, Voravit; Akpek, Gorgun; Sahovic, Entezam; Tricot, Guido J; Shaughnessy, Paul J; White, Darrell J; Rodriguez, Tulio E; Solomon, Scott R; Yu, Louie H; Zhao, Cathy; Patil, Shiva; Armstrong, Elizabeth; Smith, Angela; Elekes, Agnes; Kato, Kazunobu; Reece, Donna E.: Safety and efficacy of targeted-dose busulfan and bortezomib as a conditioning regimen for patients with relapsed multiple myeloma undergoing a second autologous blood progenitor cell transplantation. Biology of Blood & Marrow Transplantation 20 (12): 1949-57,2014.

Academic Contact Info

2 Perelman Center for Advanced Medicine
34th and Civic Center Bld
2-319S

Philadelphia, PA 19104
Phone: (215) 662-7910
Fax: (215) 662-4064
Patient appointments: 800-789-PENN (7366)

Related Links